Doshi-Velez F, Ge Y, Kohane I. Comorbidity Clusters in Autism Spectrum Disorders: An Electronic Health Record Time-Series Analysis. Pediatrics. 2014;133(1):e54-e63.
Tyler CV, Schramm SC, Karafa M, Tang AS, Jain AK. Chronic disease risks in young adults with autism spectrum disorder: forewarned is forearmed. American journal on intellectual and developmental disabilities. 2011;116(5):371-380.
Kohane IS, McMurry A, Weber G, et al. The co-morbidity burden of children and young adults with autism spectrum disorders. PloS one. 2012;7(4):e33224.
Hughes RB, Lund EM, Gabrielli J, Powers LE, Curry MA. Hughes, R. B., Lund, E. M., Gabrielli, J., Powers, L. E., & Curry, M. A. (2011). Prevalence of interpersonal violence against community-living adults with disabilities: A literature review. Rehabilitation psychology. 2011;56(4):302.
Woolfenden S, Sarkozy V, Ridley G, Coory M, Williams K. A systematic review of two outcomes in autism spectrum disorder-epilepsy and mortality. Developmental Medicine & Child Neurology. 2012;54(4):306-312.
Shavelle RM, Strauss D. Comparative Mortality of Persons with Autism in California, 1989-1996. Journal of Insurance Medicine. 1998;30(4):220-225.
Shavelle RM, Strauss DJ, Pickett J. Causes of death in autism. Journal of autism and developmental disorders. 2001;31(6):569-576.
Woolfenden, S., et al. (2012).
Viscidi, E. W., et al. (2013). "Clinical characteristics of children with autism spectrum disorder and co-occurring epilepsy." PLoS One 8(7): e67797.
Buie T, Campbell DB, Fuchs GJ, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010;125(Supplement 1):S1-S18.
Charlot L, Abend S, Ravin P, Mastis K, Hunt A, Deutsch C. Non?psychiatric health problems among psychiatric inpatients with intellectual disabilities. Journal of Intellectual Disability Research. 2011;55(2):199-209.
Tyler CV, et.al. (2011).
Kohane, IS, et.al. (2012)
de Kuijper, G., et al. (2013). "Determinants of physical health parameters in individuals with intellectual disability who use long-term antipsychotics." Res Dev Disabil 34(9): 2799-2809.
Bobo, W. V., et al. (2013). "Antipsychotics and the risk of type 2 diabetes mellitus in children and youth." JAMA Psychiatry 70(10): 1067-1075.
de Kuijper, G., et al. (2013). Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability. J Clin Psychopharmacol 33(4): 520-524.
Davis III TE, Hess JA, Moree BN, et al. Anxiety symptoms across the lifespan in people diagnosed with autistic disorder. Research in Autism Spectrum Disorders. 2011;5(1):112-118.
Allen D, Langthorne P, Tonge B, et al. Towards the Prevention of Behavioural and Psychiatric Disorders in People with Intellectual Disabilities. Journal of Applied Research in Intellectual Disabilities. 2013.
Rossignol, D. A. and R. E. Frye (2011). "Melatonin in autism spectrum disorders: a systematic review and meta-analysis." Dev Med Child Neurol 53(9): 783-792.
Hylkema, T. and C. Vlaskamp (2009). "Significant improvement in sleep in people with intellectual disabilities living in residential settings by non-pharmaceutical interventions." J Intellect Disabil Res 53(8): 695-703
Hughes RB, Lund EM, Gabrielli J, Powers LE, Curry MA. Hughes, R. B., Lund, E. M., Gabrielli, J., Powers, L. E., & Curry, M. A. (2011). Prevalence of interpersonal violence against community-living adults with disabilities: A literature review. Rehabilitation psychology. 2011;56(4):302.
Nicolaidis, C., Kripke, C.C., Raymaker, D.M. (2014) Primary Care for Adults on the Autism Spectrum Medical Clinics of North America. 98;1169-1191.
Kapp, SK (2013). Empathizing with sensory and movement differences: Moving toward sensitive understanding of autism. Frontiers in Integrative Neuroscience. 7(38)
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington, DC: American Psychiatric Association; 2013.